Loading clinical trials...
Loading clinical trials...
A Phase II Study of LEE011 (Ribociclib) in Patients With Advanced Neuroendocrine Tumors of Foregut Origin
Conditions
Interventions
Laboratory Biomarker Analysis
Pharmacological Study
+1 more
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
August 25, 2015
Primary Completion Date
June 5, 2019
Completion Date
June 5, 2019
Last Updated
October 30, 2020
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions